nature.com search

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

nature
search

Search My Account Login

advanced

where the list of authors contains where the title contains

Refine your results by…

volume

start page / article no.

Filters

Filter By:

Article type

Check one or more article types to show results from those article types only.

Research (3)

Journal

Check one or more journals to show results from those journals only.

British Journal of Cancer (2)
Cancer Gene Therapy (1)
Nature Genetics (1)

Choose more journals

Subject Check one or more subjects to show results from those subjects only.

Melanoma (2)
Cancer immunotherapy (1)
Prognostic markers (1)

Date

Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
In the last year
Last 2 years
Last 5 years

Custom date range

Sort by Relevance

Choose a way to sort results.

Relevance
Date — most recent
Date — oldest first

Loading Filters

Showing 1–4 of 4 results

Loading Filters

Research | 16 August 2019 | Open
Impact of depth of response on survival in patients treated with cobimetinib ± vemurafenib: pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM
- Karl D. Lewis
- , James Larkin
- , Antoni Ribas
- , Keith T. Flaherty
- , Grant A. McArthur
- , Paolo A. Ascierto
- , Brigitte Dréno
- , Yibing Yan
- , Matthew Wongchenko
- , Edward McKenna
- , Qian Zhu
- , Yong Mun
- & Axel Hauschild
British Journal of Cancer 121 , 522–528

Rights & permissionsfor article Impact of depth of response on survival in patients treated with cobimetinib ± vemurafenib: pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM . Opens in a new window.
13 February 2018 | Open
Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAF^V600 mutation–positive melanoma
- Brigitte Dréno
- , Paolo A Ascierto
- , Victoria Atkinson
- , Gabriella Liszkay
- , Michele Maio
- , Mario Mandalà
- , Lev Demidov
- , Daniil Stroyakovskiy
- , Luc Thomas
- , Luis de la Cruz-Merino
- , Caroline Dutriaux
- , Claus Garbe
- , Karen Bartley
- , Thomas Karagiannis
- , Ilsung Chang
- , Isabelle Rooney
- , Daniel O Koralek
- , James Larkin
- , Grant A McArthur
- & Antoni Ribas
British Journal of Cancer 118 , 777–784

Rights & permissionsfor article Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAFV600 mutation–positive melanoma . Opens in a new window.
Research | 12 March 2002
Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: Phase II randomized study comparing two dose levels
- Christoph Rochlitz
- , Brigitte Dreno
- , Peter Jantscheff
- , Franco Cavalli
- , Patrick Squiban
- , Bruce Acres
- , Martine Baudin
- , Bernard Escudier
- , Lucie Heinzerling
- , Rudolf Morant
- , Richard Herrmann
- , Pierre-Yves Dietrich
- & Reinhard Dummer
Cancer Gene Therapy 9 , 289–295

Rights & permissionsfor article Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: Phase II randomized study comparing two dose levels . Opens in a new window.
Research | 17 June 2002
Identification of SLC39A4, a gene involved in acrodermatitis enteropathica
Nature Genetics 31 , 239–240

Rights & permissionsfor article Identification of SLC39A4, a gene involved in acrodermatitis enteropathica . Opens in a new window.

Nature Research menu

Our Journals

Nature
Nature Communications
Nature Protocols
Scientific Reports
View all journals

Subjects

Biological Sciences
Scientific Community & Society
Earth & Environmental Sciences
Health Sciences
Physical Sciences
View all subjects

Contact us
Authors & Referees
Librarians
Advertisers
Press
About Nature Research

Search

Article search

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

nature.com sitemap

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
Nano
Protocol Exchange
Nature Index

Publish with us

Guide to Authors
Guide to Referees
Editorial policies
Open access
Reprints & permissions

Researcher services

Research data
Language editing
Scientific editing
Nature Masterclasses
Nature Research Academies

Libraries & institutions

Librarian service & tools
Librarian portal
Open research

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Career development

Nature Careers
Nature Conferences
Nature events

Regional websites

Nature China
Nature India
Nature Japan
Nature Korea
Nature Middle East

Refine your results by…

Filters ​

Filter By:

Impact of depth of response on survival in patients treated with cobimetinib ± vemurafenib: pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM

Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAFV600 mutation–positive melanoma

Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: Phase II randomized study comparing two dose levels

Identification of SLC39A4, a gene involved in acrodermatitis enteropathica

Search

Quick links

Filters

Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAF^V600 mutation–positive melanoma